Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of New Report Detailing Association

The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia, or male breast growth, due to the use of the antipsychotic medication. New York, New York (PRWEB) August 08, 2014 As Risperdal lawsuits (http://www.lawreward.com/risperdal/) mount in U.S. courts, Bernstein Liebhard LLP notes that yet another group of researchers has found data to support a link between exposure to risperidone, the active ingredient in the atypical antipsychotic drug, and the development of gynecomastia (male breast growth) in men. Writing in the August 6th issue of the Journal of Clin
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories